2021 Symposium

Maria Da Graça Carvalho
Member of the European Parliament

Former Senior Advisor of Commissioner for Research, Science and Innovation

Professor Fred Verzijlbergen
Professor in Nuclear Medicine

Full Professor in Nuclear Medicine in Erasmus MC Rotterdam and Radboud University Medical Center, President of the Dutch Society of Nuclear Medicine and President of the European Association of Nuclear Medicine. Emeritus since 2020.

Professor Johannes Czernin
Professor and Vice-Chair, Department of Molecular and Medical Pharmacology Chief, Ahmanson Translational Theranostics Division David Geffen of Medicine at UCLA

Dr. Johannes Czernin is a Professor of Molecular and Medical Pharmacology at the David Geffen School of Medicine at UCLA. He received his MD degree from the University of Vienna in 1983 and was board certified in Internal Medicine in Austria in 1989 and in Nuclear Medicine in 1996 in the USA. He was named Director of Nuclear Medicine at the David Geffen School of Medicine at UCLA in 1996 and currently serves as the Chief of the Ahmanson Translational Theranostics Division at UCLA. The Division includes the Nuclear Medicine Clinic, a clinical imaging research program, a drug and probe development program with a strong underpinning in tumor biology, a preclinical imaging and biomedical radiochemistry center. His group successfully applied to the FDA for an NDA for a PSMA targeted PET imaging probe in prostate cancer. The Division collaborates within the department of molecular and medical pharmacology and across several other departments including urology, radiation oncology, oncology, surgery, radiology, neurology, pathology and others to advance preclinical and clinical theranostics. Dr. Czernin is currently Editorin-Chief of the Journal of Nuclear Medicine and is a past president of the Academy of Molecular Imaging. He has published more than 280 peer-reviewed research papers.

Professor Jolanta Kunikowska
EANM President

Prof. Jolanta Kunikowska is a nuclear medicine as well as internal medicine physician specialist. She is currently professor at the Nuclear Medicine Department, Medical University, Warsaw/Poland. She has a broad interest in positron emission tomography (PET), molecular imaging applications in oncology and theragnostics (radionuclide therapy). She has a particular interest in novel PET radiotracers, and theragnostic applications including prostate, neuroendocrine tumors and glioblastoma. She has authored over 100 peer-reviewed articles and several book chapters. She received several prestigious awards provided by various scientific communities including the Gold prize for Hisada award in 2018 and Marie Curie Award for outstanding scientific work presented at the 29th Annual Congress of the European Association of Nuclear Medicine (EANM) in Barcelona in 2016. She is currently the President of the EANM.

Professor Ken Herrmann
Chair of the Department of Nuclear Medicine at the Universitätsklinikum EssenAdjunct Professor at the Ahmanson Translational Imaging Division of the Department of Molecular and Medical Pharmacology at UCLA, Chair of the EANM Oncology & Theranostics committee and Section Editor of the Journal of Nuclear Medicine.

Prof. Dr. Ken Herrmann, MBA graduated from Charite Berlin Medical School in 2004 after completing away electives and ERASMUS exchanges in France, Switzerland, Chile and the US. In 2007 he received the Doctors Degree from Humboldt Universität Berlin with his work „Expression and function of A1 adenosine receptors in gliomas“. In 2011 he completed the executive MBA program at Universität Zürich, Switzerland. Professor Herrmann completed his residency in Nuclear Medicine at Klinikum rechts der Isar, Technische Universität München, as well as his habilitation titled „In Vivo-Proliferation Imaging with 3´deoxy-3´-[18F]Fluorothymidine PET in Oncology“. In May 2011 he joined as Visiting Assistant Professor and was later promoted to tenure track Associate Professor in the Ahmanson Translational Imaging Division of the Department of Molecular and Medical Pharmacology at the University of California Los Angeles (UCLA). From August 2012 to July 2016 he served as Vice Chair of the Department of Nuclear Medicine at Universitätsklinikum Würzburg. Since August 2016 Professor Herrmann acts as Chair of the Department of Nuclear Medicine at the Universitätsklinikum Essen He also is currently the Chair of the EANM Oncology & Theranostics committee and Section Editor of the Journal of Nuclear Medicine.

Professor Nicola Fazio
Director of the Division of Gastrointestinal Medical Oncology and Neuroendocrine Tumours and Director of the Programme in Digestive and Neuroendocrine Tumours at the European Institute of Oncology, in Milan, Italy

Graduated at the University of L’Aquila, Italy, Faculty of Medicine and Surgery, in 1988. Specialised in Internal Medicine, in L’Aquila, in 1993.
Specialised in Oncology, in Milan, in 2002. In 2013 PhD in Digestive Oncology. Currently he is Director of the Division of Gastrointestinal Medical Oncology and Neuroendocrine Tumors and Director of Program in Digestive and Neuroendocrine Tumors at the European Institute of Oncology (IEO), in Milan, where he has been working since 1995.
Since 2015 he is head of the IEO ENETS Center of Excellence for GEP NETs
He has been serving as ESMO Faculty Coordinator for Neuroendocrine, Endocrine and CUP for the period 2016-2019. He served as co-chair of ESMO NEN Preceptorship in 2017, 2018, and 2019 editions and he will co-chair the 2021 edition. He served as co-chair of the first ESMO NEN Advanced Course in 2019 and he will co-chair the 2021 edition. He was coordinator of Italian (AIOM/ITANET) neuroendocrine neoplasms guidelines for the period 2013-2019. He was member of the ENETS Advisory Board for the period 2015-2019, Advisory Board Chairman for 2019-2020, and Executive Committee Member since 2020. 

Mart-Jan Blauwhoff
Scientific Marketing Director at Curium Pharma
Co-chairman of the NMEU Communication WG

Dr. Helen Barker
Vice President Regulatory Affairs, Blue Earth Diagnostics
Chair of the NMEU RA&Q Working Group

Adam Smith
Moderator

Adam Smith is Chief Scientific Officer of the Nobel Foundation’s media company, Nobel Media AB. After Fellowships in molecular biology, neuroscience and physiology in Oxford, Harvard and Heidelberg he pursued research in developmental neuroscience at Oxford University before moving into science publishing. At Nature Publishing Group he launched Nature Reviews Drug Discovery as Chief Editor and then, as Publisher, ran Nature’s Biopharma portfolio of journals. In his current role, his projects include recording an archive of interviews with all living Nobel Laureates, running an educational programme that takes Laureates to meet and inspire scientists around the world, and putting together the programmes of Nobel Media’s global science & society meeting series, the Nobel Prize Dialogues.